106 related articles for article (PubMed ID: 17877432)
1. The role of mTOR inhibition in augmenting radiation induced autophagy.
Jaboin JJ; Shinohara ET; Moretti L; Yang ES; Kaminski JM; Lu B
Technol Cancer Res Treat; 2007 Oct; 6(5):443-7. PubMed ID: 17877432
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.
Cao C; Subhawong T; Albert JM; Kim KW; Geng L; Sekhar KR; Gi YJ; Lu B
Cancer Res; 2006 Oct; 66(20):10040-7. PubMed ID: 17047067
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells.
Paglin S; Lee NY; Nakar C; Fitzgerald M; Plotkin J; Deuel B; Hackett N; McMahill M; Sphicas E; Lampen N; Yahalom J
Cancer Res; 2005 Dec; 65(23):11061-70. PubMed ID: 16322256
[TBL] [Abstract][Full Text] [Related]
4. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer.
Kim KW; Hwang M; Moretti L; Jaboin JJ; Cha YI; Lu B
Autophagy; 2008 Jul; 4(5):659-68. PubMed ID: 18424912
[TBL] [Abstract][Full Text] [Related]
5. The mTOR inhibitor RAD001 augments radiation-induced growth inhibition in a hepatocellular carcinoma cell line by increasing autophagy.
Altmeyer A; Josset E; Denis JM; Gueulette J; Slabbert J; Mutter D; Noël G; Bischoff P
Int J Oncol; 2012 Oct; 41(4):1381-6. PubMed ID: 22895785
[TBL] [Abstract][Full Text] [Related]
6. Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy.
Fujiwara K; Iwado E; Mills GB; Sawaya R; Kondo S; Kondo Y
Int J Oncol; 2007 Oct; 31(4):753-60. PubMed ID: 17786305
[TBL] [Abstract][Full Text] [Related]
7. MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1.
Wang Y; Hu Z; Liu Z; Chen R; Peng H; Guo J; Chen X; Zhang H
Autophagy; 2013 Dec; 9(12):2069-86. PubMed ID: 24189100
[TBL] [Abstract][Full Text] [Related]
8. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.
Takeuchi H; Kondo Y; Fujiwara K; Kanzawa T; Aoki H; Mills GB; Kondo S
Cancer Res; 2005 Apr; 65(8):3336-46. PubMed ID: 15833867
[TBL] [Abstract][Full Text] [Related]
9. The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer.
Leisching GR; Loos B; Botha MH; Engelbrecht AM
Toxicology; 2015 Sep; 335():72-8. PubMed ID: 26201060
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of induced autophagy increases apoptosis of Nara-H cells.
Nakamura O; Hitora T; Akisue T; Kawamoto T; Yamagami Y; Yamamoto T
Int J Oncol; 2011 Dec; 39(6):1545-52. PubMed ID: 21805033
[TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
[TBL] [Abstract][Full Text] [Related]
12. Prolonged autophagy by MTOR inhibitor leads radioresistant cancer cells into senescence.
Nam HY; Han MW; Chang HW; Kim SY; Kim SW
Autophagy; 2013 Oct; 9(10):1631-2. PubMed ID: 23989658
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.
Gibbons JJ; Abraham RT; Yu K
Semin Oncol; 2009 Dec; 36 Suppl 3():S3-S17. PubMed ID: 19963098
[TBL] [Abstract][Full Text] [Related]
14. NCCN Task Force Report: mTOR inhibition in solid tumors.
Figlin RA; Brown E; Armstrong AJ; Akerley W; Benson AB; Burstein HJ; Ettinger DS; Febbo PG; Fury MG; Hudes GR; Kies MS; Kwak EL; Morgan RJ; Mortimer J; Reckamp K; Venook AP; Worden F; Yen Y
J Natl Compr Canc Netw; 2008 Sep; 6 Suppl 5():S1-20; quiz S21-2. PubMed ID: 18926092
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin is a neuroprotective treatment for traumatic brain injury.
Erlich S; Alexandrovich A; Shohami E; Pinkas-Kramarski R
Neurobiol Dis; 2007 Apr; 26(1):86-93. PubMed ID: 17270455
[TBL] [Abstract][Full Text] [Related]
16. Pathways that regulate autophagy and their role in mediating tumor response to treatment.
Paglin S; Yahalom J
Autophagy; 2006; 2(4):291-3. PubMed ID: 16921271
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.
Eshleman JS; Carlson BL; Mladek AC; Kastner BD; Shide KL; Sarkaria JN
Cancer Res; 2002 Dec; 62(24):7291-7. PubMed ID: 12499272
[TBL] [Abstract][Full Text] [Related]
18. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways.
Wang Y; Qiu Q; Shen JJ; Li DD; Jiang XJ; Si SY; Shao RG; Wang Z
Int J Biochem Cell Biol; 2012 Nov; 44(11):1813-24. PubMed ID: 22750415
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin treatment inhibits CHO cell death in a serum-free suspension culture by autophagy induction.
Lee JS; Lee GM
Biotechnol Bioeng; 2012 Dec; 109(12):3093-102. PubMed ID: 22627923
[TBL] [Abstract][Full Text] [Related]
20. mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.
Wysocki PJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):231-41. PubMed ID: 19379082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
